Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 12/20 | 0.49 |
| ▸ | ADORA2B | P29275 | 5/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | PDE5A | O76074 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708002 | 1.00 | ADORA3 (0.49) | ADORA3ADORA2BADORA2AKMT2AADORA1 | |
| SCHEMBL9708675 | 0.96 | KMT2A (0.45) | ADORA3ADORA2BADORA2AKMT2AADORA1 | |
| SCHEMBL9708332 | 0.96 | PDE5A (0.46) | ADORA3ADORA2BADORA2AKMT2AADORA1 | |
| SCHEMBL9707438 | 0.96 | ADORA3 (0.49) | ADORA3ADORA2BADORA2AKMT2AADORA1 | |
| SCHEMBL9708043 | 0.95 | PDE5A (0.47) | ADORA3KMT2AADORA1PDE5A | |
| SCHEMBL9708170 | 0.93 | ADORA3 (0.48) | ADORA3ADORA2BADORA2AKMT2AADORA1 | |
| SCHEMBL9708354 | 0.93 | KMT2A (0.47) | ADORA3KMT2A | |
| SCHEMBL9708212 | 0.93 | KMT2A (0.46) | ADORA3KMT2A | |
| SCHEMBL9708008 | 0.93 | ADORA3 (0.46) | ADORA3ADORA2BADORA2AKMT2AADORA1 | |
| SCHEMBL9707831 | 0.92 | KMT2A (0.43) | ADORA3ADORA2BKMT2APDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |